Veregen is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Pharmaderm A Division Of Fougera Pharmaceuticals Inc.. The primary component is Sinecatechins.
| Product ID | 10337-450_0ca583df-02a1-4c94-a48f-5270790ee3b7 |
| NDC | 10337-450 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Veregen |
| Generic Name | Sinecatechins |
| Dosage Form | Ointment |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2007-12-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021902 |
| Labeler Name | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Substance Name | SINECATECHINS |
| Active Ingredient Strength | 150 mg/g |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2007-12-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021902 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-12-14 |
| Marketing Category | NDA |
| Application Number | NDA021902 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-12-14 |
| Marketing Category | NDA |
| Application Number | NDA021902 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-12-14 |
| Marketing Category | NDA |
| Application Number | NDA021902 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2007-12-14 |
| Ingredient | Strength |
|---|---|
| SINECATECHINS | 150 mg/g |
| SPL SET ID: | 2c1cd745-79ab-487d-b759-995794cedb92 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10337-450 | Veregen | sinecatechins |
| 62559-385 | Veregen | sinecatechins |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VEREGEN 78979942 3424798 Live/Registered |
FOUGERA PHARMACEUTICALS INC. 2006-04-17 |
![]() VEREGEN 78862546 not registered Dead/Abandoned |
MEDIGENE AG 2006-04-17 |